MoneyWorks4Me

Sai Parenterals’ arm renews long-term OTC medicines supply contract

26 Aug 2026 Evaluate

Sai Parenterals’ subsidiary -- Noumed Pharmaceuticals has renewed its long-term OTC medicines supply agreement with one of Australia's leading, multi-billion-dollar pharmacy chains with an expanded product portfolio, a long agreement tenure, and a higher agreement value. The renewed agreement is for a 3-year term with a projected value of 30 million Australian Dollar, at an exchange rate of Rs 68.52 aggregating to around Rs 204 crore.  

Sai Parenterals, along with its subsidiaries, carries out contract research and manufacturing activities for customers engaged in pharmaceutical industries.

Sai Parenterals Share Price

519.30 1.20 (0.23%)
04-Sep-2026 14:16 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.10
Dr. Reddys Labs. 1158.00
Cipla 1380.55
Lupin 2110.00
Zydus Lifesciences 1129.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: